Monoaminergic Modulation of Motor Function in Subacute Incomplete Spinal Cord Injury (SCI)

NCT01753882 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Spinal Cord Injury

Interventions

DRUG: Lexapro
DRUG: Placebo

Sponsor

Shirley Ryan AbilityLab